Patents by Inventor Robert G. Johnson, Jr.

Robert G. Johnson, Jr. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220401581
    Abstract: Nucleic acid sequences encoding improved Herpes Simplex Virus Thymidine Kinases are provided, including their use in diagnostic and therapeutic applications. The thymidine kinases may be mutated using conservative mutations, non-conservative mutations, or both. Also provided are gene therapeutic systems, including viral and retroviral particles.
    Type: Application
    Filed: June 17, 2022
    Publication date: December 22, 2022
    Inventors: John P. LEVY, Rebecca A. REED, Joseph McNULTY, Robert G. JOHNSON, JR.
  • Patent number: 11364307
    Abstract: Nucleic acid sequences encoding improved Herpes Simplex Virus Thymidine Kinases are provided, including their use in diagnostic and therapeutic applications. The thymidine kinases may be mutated using conservative mutations, non-conservative mutations, or both. Also provided are gene therapeutic systems, including viral and retroviral particles.
    Type: Grant
    Filed: February 21, 2020
    Date of Patent: June 21, 2022
    Assignee: GENVIVO, INC.
    Inventors: John P. Levy, Rebecca A Reed, Joseph McNulty, Robert G. Johnson, Jr.
  • Patent number: 11253611
    Abstract: Nucleic acid sequences encoding improved Herpes Simplex Virus Thymidine Kinases are provided, including their use in diagnostic and therapeutic applications. The thymidine kinases may be mutated using conservative mutations, non-conservative mutations, or both. Also provided are gene therapeutic systems, including viral and retroviral particles.
    Type: Grant
    Filed: July 12, 2019
    Date of Patent: February 22, 2022
    Assignee: GENVIVO, INC.
    Inventors: John P. Levy, Rebecca A. Reed, Joseph McNulty, Robert G. Johnson, Jr.
  • Patent number: 10610603
    Abstract: Nucleic acid sequences encoding improved Herpes Simplex Virus Thymidine Kinases are provided, including their use in diagnostic and therapeutic applications. The thymidine kinases may be mutated using conservative mutations, non-conservative mutations, or both. Also provided are gene therapeutic systems, including viral and retroviral particles.
    Type: Grant
    Filed: February 8, 2018
    Date of Patent: April 7, 2020
    Assignee: GenVivo, Inc.
    Inventors: John P. Levy, Rebecca A. Reed, Joseph McNulty, Robert G. Johnson, Jr.
  • Publication number: 20190328904
    Abstract: Nucleic acid sequences encoding improved Herpes Simplex Virus Thymidine Kinases are provided, including their use in diagnostic and therapeutic applications. The thymidine kinases may be mutated using conservative mutations, non-conservative mutations, or both. Also provided are gene therapeutic systems, including viral and retroviral particles.
    Type: Application
    Filed: July 12, 2019
    Publication date: October 31, 2019
    Inventors: John P. LEVY, Rebecca A. REED, Joseph MCNULTY, Robert G. JOHNSON, Jr.
  • Patent number: 10350302
    Abstract: Nucleic acid sequences encoding improved Herpes Simplex Virus Thymidine Kinases are provided, including their use in diagnostic and therapeutic applications. The thymidine kinases may be mutated using conservative mutations, non-conservative mutations, or both. Also provided are gene therapeutic systems, including viral and retroviral particles.
    Type: Grant
    Filed: May 31, 2018
    Date of Patent: July 16, 2019
    Assignee: GenVivo, Inc.
    Inventors: John P. Levy, Rebecca A. Reed, Joseph McNulty, Robert G. Johnson, Jr.
  • Publication number: 20180264137
    Abstract: Nucleic acid sequences encoding improved Herpes Simplex Virus Thymidine Kinases are provided, including their use in diagnostic and therapeutic applications. The thymidine kinases may be mutated using conservative mutations, non-conservative mutations, or both. Also provided are gene therapeutic systems, including viral and retroviral particles.
    Type: Application
    Filed: May 31, 2018
    Publication date: September 20, 2018
    Inventors: John P. LEVY, Rebecca A. REED, Joseph MCNULTY, Robert G. JOHNSON, JR.
  • Publication number: 20180236101
    Abstract: Nucleic acid sequences encoding improved Herpes Simplex Virus Thymidine Kinases are provided, including their use in diagnostic and therapeutic applications. The thymidine kinases may be mutated using conservative mutations, non-conservative mutations, or both. Also provided are gene therapeutic systems, including viral and retroviral particles.
    Type: Application
    Filed: February 8, 2018
    Publication date: August 23, 2018
    Inventors: John P. LEVY, Rebecca A. REED, Joseph McNULTY, Robert G. JOHNSON, Jr.
  • Patent number: 9999683
    Abstract: Nucleic acid sequences encoding improved Herpes Simplex Virus Thymidine Kinases are provided, including their use in diagnostic and therapeutic applications. The thymidine kinases may be mutated using conservative mutations, non-conservative mutations, or both. Also provided are gene therapeutic systems, including viral and retroviral particles.
    Type: Grant
    Filed: March 14, 2014
    Date of Patent: June 19, 2018
    Assignee: EPEIUS BIOTECHNOLOGIES CORPORATION
    Inventors: John P. Levy, Rebecca A. Reed, Joseph McNulty, Robert G. Johnson, Jr.
  • Patent number: 9925276
    Abstract: Nucleic acid sequences encoding improved Herpes Simplex Virus Thymidine Kinases are provided, including their use in diagnostic and therapeutic applications. The thymidine kinases may be mutated using conservative mutations, non-conservative mutations, or both. Also provided are gene therapeutic systems, including viral and retroviral particles.
    Type: Grant
    Filed: March 14, 2014
    Date of Patent: March 27, 2018
    Assignee: EPEIUS BIOTECHNOLOGIES CORPORATION
    Inventors: John P. Levy, Rebecca A. Reed, Joseph McNulty, Robert G. Johnson, Jr.
  • Publication number: 20140294772
    Abstract: Nucleic acid sequences encoding improved Herpes Simplex Virus Thymidine Kinases are provided, including their use in diagnostic and therapeutic applications. The thymidine kinases may be mutated using conservative mutations, non-conservative mutations, or both. Also provided are gene therapeutic systems, including viral and retroviral particles.
    Type: Application
    Filed: March 14, 2014
    Publication date: October 2, 2014
    Applicant: Epeius Biotechnologies Corporation
    Inventors: John P. LEVY, Rebecca A. REED, Joseph MCNULTY, Robert G. JOHNSON, JR.
  • Publication number: 20140288163
    Abstract: Nucleic acid sequences encoding improved Herpes Simplex Virus Thymidine Kinases are provided, including their use in diagnostic and therapeutic applications. The thymidine kinases may be mutated using conservative mutations, non-conservative mutations, or both. Also provided are gene therapeutic systems, including viral and retroviral particles.
    Type: Application
    Filed: March 14, 2014
    Publication date: September 25, 2014
    Inventors: John P. LEVY, Rebecca A. REED, Joseph MCNULTY, Robert G. JOHNSON, JR.
  • Patent number: 7691392
    Abstract: A method for treating multiple myeloma in a subject by administering 17-allylamino-17-demethoxy-geldanamycin or 17-amino geldanamycin, or a prodrug of either 17-AAG or 17-AG, to the subject.
    Type: Grant
    Filed: April 26, 2006
    Date of Patent: April 6, 2010
    Assignee: Kosan Biosciences Incorporated
    Inventors: Robert G. Johnson, Jr., Alison L. Hannah, Gillian F. Cropp, Yiqing Zhou, J. Michael Sherrill
  • Patent number: 7091193
    Abstract: Formulations comprising one or more epothilones together with a pharmaceutically acceptable carrier, in particular such pharmaceutical compositions suitable for oral administration of an epothilone.
    Type: Grant
    Filed: October 9, 2003
    Date of Patent: August 15, 2006
    Assignee: Kosan biosciences Incorporated
    Inventors: Michael J. Sherrill, Robert G. Johnson, Jr.
  • Patent number: 6396474
    Abstract: A method and apparatus providing visual feedback to a computer user while dragging selected text is described. As its first step, the processing logic creates a text object from the selected text once the computer user has initiated a drag. Simultaneously, the selected text is visually de-emphasized. Secondly, the processing logic snaps the text object to the cursor so that the text object follows the cursor without obscuring text at the insertion point. Finally, when the computer user selects the final insertion point, the selected text is visually zoomed from the source location to the final insertion point.
    Type: Grant
    Filed: November 26, 1997
    Date of Patent: May 28, 2002
    Assignee: Apple Computer, Inc.
    Inventors: Robert G. Johnson, Jr., Scott Jenson
  • Patent number: 4999001
    Abstract: An apparatus including a playing board defined by a generally circular configuration, including a planar top surface with four equally spaced recessed triangulated player sections, wherein each player section includes a predetermined number of numbered recesses therewithin to correspond with four different colored sets of correspondingly numbered spheres. The spheres are positionable within a rotating tumbler and are permitted to be removed from the tumbler in a one-at-a-time sequence for selective association with one of said recesses. A further series of white spheres and a further series of black spheres are provided to direct respectively a free turn for the player and "wild" spheres for the black spheres for use with any number or coloration. Each player must utilize a corresponding coloration for a corresponding player position. Additionally, a plurality of dice are utilized to direct play in sequence about the board game.
    Type: Grant
    Filed: May 7, 1990
    Date of Patent: March 12, 1991
    Inventor: Robert G. Johnson, Jr.